Skip to main content
. 2017 May 18;27(11):4767–4774. doi: 10.1007/s00330-017-4858-0

Fig. 5.

Fig. 5

Ladder plots showing tumour ADC (A) and conspicuity (B) changes over 6 months for each of the two arms included in the study. The error bars at 6 months confirm a significant increase in ADC and decrease in conspicuity in men treated with dutasteride (red, dashed line) when compared to men in the placebo arm (blue, continuous line)